Technical Comparison
NVIDIA Corporation - Common Stock vs Recursion Pharmaceuticals, Inc. - Class A Common Stock
Real-time financial comparison matrix between NVDA and RXRX.
Primary Asset
NVD
NVIDIA Corporation - Common Stock
Market Rank #101Live Price$197.01
Market Capitalization$4.8T
24h Change+0.25%
Circulating Supply24B NVDA
Comparison Asset
RXR
Recursion Pharmaceuticals, Inc. - Class A Common Stock
Market Rank #1004267Live Price$3.05
Market Capitalization$1.6B
24h Change+1.33%
Circulating Supply525M RXRX
Market Metric Matrix
| Comparison Metric | NVDA Value | RXRX Value | Dominant Asset |
|---|---|---|---|
| Market Cap Rank | #101 | #1004267 | NVIDIA Corporation - Common Stock |
| Unit Price Valuation | $197.01 | $3.05 | NVIDIA Corporation - Common Stock |
| Total Liquid Cap | $4.8T | $1.6B | NVIDIA Corporation - Common Stock |
Frequently Asked Questions
Is NVIDIA Corporation - Common Stock bigger than Recursion Pharmaceuticals, Inc. - Class A Common Stock?
NVIDIA Corporation - Common Stock has a market cap of $4.8T, while Recursion Pharmaceuticals, Inc. - Class A Common Stock sits at $1.6B. Therefore, NVIDIA Corporation - Common Stock is currently the larger financial asset by market capitalization.
What is the price ratio between NVIDIA Corporation - Common Stock and Recursion Pharmaceuticals, Inc. - Class A Common Stock?
Currently, 1 NVDA is worth 64.59 RXRX.